PROMOTING ACCESS TO AFRICAN RESEARCH

East African Medical Journal

The AJOL site is currently undergoing a major upgrade, and there will temporarily be some restrictions to the available functionality.
-- Users will not be able to register or log in during this period.
-- Full text (PDF) downloads of Open Access journal articles will be available as always.
-- Full text (PDF) downloads of subscription based journal articles will NOT be available
We apologise for any inconvenience caused. Please check back soon, as we will revert to usual policy as soon as possible.





DOWNLOAD FULL TEXT Open Access  DOWNLOAD FULL TEXT Subscription or Fee Access

Complete remission of an advanced hormone receptor positive Her2-negative breast cancer treated by first line palbociclib-letrozole and local treatment

Z Benbrahim, L Amaadour, K Oualla, A Alj, C Bouchikhi, N Mellas

Abstract


The palbociclib-letrozole combination has revolutionized the treatment of Hormone-receptor-positive Her2-negative advanced breast cancers. The aim of the inclusion of targeted agents in endocrine based therapy is to prolong hormonsensitivity and to delay the initiation of subsequent chemotherapy, especially for patients with low disease burden. However, the interest of locoregional treatment after response to initial therapy in advanced disease still investigational especially in the era of biotherapy. In the present case report, we showed the possible complete response with hormone-therapy associated to targeted therapy and highlighted the role of loco-regional treatment in this situation.

Full Text:


No subscription journal articles available during site upgrade.



AJOL African Journals Online